M. Langlois

The 5‐HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5‐HT4(c) receptor

R. Fischmeister, O. Blondel, M. Gastineau, 1998, British journal of pharmacology.

Pharmacological characterization of the human 5‐HT4(d) receptor splice variant stably expressed in Chinese hamster ovary cells

F. Lezoualc’h, R. Fischmeister, M. Langlois, 2000, British journal of pharmacology.

5‐HT4 receptor agonists increase sAPPα levels in the cortex and hippocampus of male C57BL/6j mice

F. Lezoualc’h, H. Devijver, F. Leuven, 2007, British Journal of Pharmacology.

PAPER 5-HT 4 receptor agonists increase sAPP a levels in the cortex and hippocampus of male C 57 BL / 6 j mice

F. Lezoualc’h, H. Devijver, F. Leuven, 2007 .

Intestinal prokinesia by two esters of 4-amino-5-chloro-2- methoxybenzoic acid: involvement of 5-hydroxytryptamine-4 receptors and dissociation from cardiac effects in vivo.

M. Langlois, F. De Ponti, T. Croci, 1999, The Journal of pharmacology and experimental therapeutics.

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

A. Villaflor, M. Pfeffer, C. Held, 2021, European heart journal.

Prucalopride and donepezil act synergistically to reverse scopolamine-induced memory deficit in C57Bl/6j mice

C. Belzung, F. Lezoualc’h, M. Langlois, 2008, Behavioural Brain Research.

Analysis of the contribution of receptor subdomains to the cooperative binding and internalization of transforming growth factor-beta (TGF-beta) type I and type II receptors.

M. O’Connor-McCourt, C. Collins, M. Langlois, 2008, Experimental cell research.